ANNPO Bio has invested more than twenty million RMB in R&D equipment. The technical group has accumulated a massive amount of working experience in the development of bio-pharmaceautical products.Recently, the company made a heavy investment in building a pilot facility which included bulk manufacturing and fill-finish suites.

       The pilot plant is designed to fit the scale of 500L mammal cell culture bioreactors and meets the cGMP guidelines of both Chinese and European authorities. The facility will be used for internal projects as well as providing manufacturing services.